Concepedia

Shu Sahara

SS

21

Publications

916

Citations

15

H-Index

2012

Active since

Affiliations

Hamamatsu University School of Medicine(Current)

Shiga University of Medical Science Hospital

Hamamatsu University

JA Shizuoka Koseiren ENSHU hospital

Center for Clinical Research (United States)

Shu Sahara is an author at Hamamatsu University School of Medicine specializing in medicine, pharmacotherapy, and pharmacology.

ORCID

Top concepts

Publications per year

2012–2017

21

Publications

21

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to<scp>CYP</scp>2C19 genotype

Takuma Kagami, Shu Sahara, H. Ichikawa et al. · Alimentary Pharmacology & Therapeutics · 2016 · 247 citations · Full text

Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer

Mitsushige Sugimoto, Hiromitsu Ban, Hitomi Ichikawa et al. · Internal Medicine · 2017 · 119 citations · Full text

, , +14

Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole

Shu Sahara, Mitsushige Sugimoto, Takahiro Uotani et al. · Alimentary Pharmacology & Therapeutics · 2013 · 68 citations · Full text

Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming <scp>CYP</scp>2<scp>C</scp>19 genotype

Mitsushige Sugimoto, Naohito Shirai, Masafumi Nishino et al. · Alimentary Pharmacology & Therapeutics · 2012 · 59 citations

Efficacy of Tailored <i>Helicobacter pylori</i> Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion

Mitsushige Sugimoto, Takahiro Uotani, Shu Sahara et al. · Helicobacter · 2014 · 54 citations

Rows per page

1–5 of 21